| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| LLY - Eli Lilly and Company | BUY | 3,124 @ USD 1071.44 | USD 3,347,179 | The ETF bought 3124 new shares of LLY (Eli Lilly and Company). The shares were bought for an average price of 1071.44 compared to the previous average buy price of 848.103. This is 26.3% higher than average price of previous purchases of LLY. |
| JNJ - Johnson & Johnson | BUY | 11,267 @ USD 206.37 | USD 2,325,171 | The ETF bought 11267 new shares of JNJ (Johnson & Johnson). The shares were bought for an average price of 206.37 compared to the previous average buy price of 174.951. This is 18.0% higher than average price of previous purchases of JNJ. |
| ABBV - AbbVie Inc | BUY | 8,284 @ USD 226.82 | USD 1,878,977 | The ETF bought 8284 new shares of ABBV (AbbVie Inc). The shares were bought for an average price of 226.82 compared to the previous average buy price of 206.893. This is 9.6% higher than average price of previous purchases of ABBV. |
| UNH - UnitedHealth Group Incorporated | BUY | 4,362 @ USD 327.42 | USD 1,428,206 | The ETF bought 4362 new shares of UNH (UnitedHealth Group Incorporated). The shares were bought for an average price of 327.42 compared to the previous average buy price of 407.683. This is -19.7% lower than average price of previous purchases of UNH. |
| ABT - Abbott Laboratories | BUY | 6,739 @ USD 125.45 | USD 845,408 | The ETF bought 6739 new shares of ABT (Abbott Laboratories). The shares were bought for an average price of 125.45 compared to the previous average buy price of 128.684. This is -2.5% lower than average price of previous purchases of ABT. |
| AMGN - Amgen Inc | BUY | 2,430 @ USD 327.38 | USD 795,533 | The ETF bought 2430 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 327.38 compared to the previous average buy price of 304.329. This is 7.6% higher than average price of previous purchases of AMGN. |
| BSX - Boston Scientific Corporation | BUY | 6,777 @ USD 95.61 | USD 647,949 | The ETF bought 6777 new shares of BSX (Boston Scientific Corporation). The shares were bought for an average price of 95.61 compared to the previous average buy price of 99.2087. This is -3.6% lower than average price of previous purchases of BSX. |
| BSX - MULSTRXSSXIMETFP | BUY | 6,777 @ USD 95.61 | USD 647,949 | The ETF bought 6777 new shares of BSX (MULSTRXSSXIMETFP). The shares were bought for an average price of 95.61 compared to the previous average buy price of 99.2087. This is -3.6% lower than average price of previous purchases of BSX. |
| MDT - Medtronic PLC | BUY | 6,452 @ USD 98.63 | USD 636,361 | The ETF bought 6452 new shares of MDT (Medtronic PLC). The shares were bought for an average price of 98.63 compared to the previous average buy price of 92.1519. This is 7.0% higher than average price of previous purchases of MDT. |
| GILD - Guild Esports Plc | BUY | 4,971 @ USD 124.29 | USD 617,846 | The ETF bought 4971 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 124.29 compared to the previous average buy price of 111.763. This is 11.2% higher than average price of previous purchases of GILD. |
| PFE - Pfizer Inc | BUY | 21,997 @ USD 25.19 | USD 554,104 | The ETF bought 21997 new shares of PFE (Pfizer Inc). The shares were bought for an average price of 25.19 compared to the previous average buy price of 25.3863. This is -0.8% lower than average price of previous purchases of PFE. |
| BMY - Bloomsbury Publishing Plc | BUY | 9,817 @ USD 54.19 | USD 531,983 | The ETF bought 9817 new shares of BMY (Bloomsbury Publishing Plc). The shares were bought for an average price of 54.19 compared to the previous average buy price of 51.7826. This is 4.6% higher than average price of previous purchases of BMY. |
| SYK - Stryker Corporation | BUY | 1,397 @ USD 355.2 | USD 496,214 | The ETF bought 1397 new shares of SYK (Stryker Corporation). The shares were bought for an average price of 355.2 compared to the previous average buy price of 373.859. This is -5.0% lower than average price of previous purchases of SYK. |
| CVS - CVS Health Corp | BUY | 6,251 @ USD 77.72 | USD 485,828 | The ETF bought 6251 new shares of CVS (CVS Health Corp). The shares were bought for an average price of 77.72 compared to the previous average buy price of 70.0444. This is 11.0% higher than average price of previous purchases of CVS. |
| MRK - Marks Electrical Group PLC | BUY | 4,116 @ USD 101.09 | USD 416,086 | The ETF bought 4116 new shares of MRK (Marks Electrical Group PLC). The shares were bought for an average price of 101.09 compared to the previous average buy price of 90.1809. This is 12.1% higher than average price of previous purchases of MRK. |
| MRK - Merck & Company Inc | BUY | 4,116 @ USD 101.09 | USD 416,086 | The ETF bought 4116 new shares of MRK (Merck & Company Inc). The shares were bought for an average price of 101.09 compared to the previous average buy price of 90.1809. This is 12.1% higher than average price of previous purchases of MRK. |
| TMO - Time Out Group plc | BUY | 621 @ USD 567.83 | USD 352,622 | The ETF bought 621 new shares of TMO (Time Out Group plc). The shares were bought for an average price of 567.83 compared to the previous average buy price of 521.892. This is 8.8% higher than average price of previous purchases of TMO. |
| CI - Cigna Corp | BUY | 1,270 @ USD 271.89 | USD 345,300 | The ETF bought 1270 new shares of CI (Cigna Corp). The shares were bought for an average price of 271.89 compared to the previous average buy price of 298.372. This is -8.9% lower than average price of previous purchases of CI. |
| COR - Cencora Inc. | BUY | 981 @ USD 340.93 | USD 334,452 | The ETF bought 981 new shares of COR (Cencora Inc.). The shares were bought for an average price of 340.93 compared to the previous average buy price of 302.142. This is 12.8% higher than average price of previous purchases of COR. |
| IDXX - IDEXX Laboratories Inc | BUY | 458 @ USD 700.34 | USD 320,756 | The ETF bought 458 new shares of IDXX (IDEXX Laboratories Inc). The shares were bought for an average price of 700.34 compared to the previous average buy price of 569.15. This is 23.1% higher than average price of previous purchases of IDXX. |
| BDX - Becton Dickinson and Company | BUY | 1,629 @ USD 195.59 | USD 318,616 | The ETF bought 1629 new shares of BDX (Becton Dickinson and Company). The shares were bought for an average price of 195.59 compared to the previous average buy price of 204.877. This is -4.5% lower than average price of previous purchases of BDX. |
| IQV - IQVIA Holdings Inc | BUY | 1,304 @ USD 220.69 | USD 287,780 | The ETF bought 1304 new shares of IQV (IQVIA Holdings Inc). The shares were bought for an average price of 220.69 compared to the previous average buy price of 196.033. This is 12.6% higher than average price of previous purchases of IQV. |
| STE - STERIS plc | BUY | 1,063 @ USD 254.34 | USD 270,363 | The ETF bought 1063 new shares of STE (STERIS plc). The shares were bought for an average price of 254.34 compared to the previous average buy price of 236.968. This is 7.3% higher than average price of previous purchases of STE. |
| WST - West Pharmaceutical Services Inc | BUY | 960 @ USD 272.54 | USD 261,638 | The ETF bought 960 new shares of WST (West Pharmaceutical Services Inc). The shares were bought for an average price of 272.54 compared to the previous average buy price of 258.129. This is 5.6% higher than average price of previous purchases of WST. |
| DGX - Quest Diagnostics Incorporated | BUY | 1,448 @ USD 176.06 | USD 254,935 | The ETF bought 1448 new shares of DGX (Quest Diagnostics Incorporated). The shares were bought for an average price of 176.06 compared to the previous average buy price of 175.624. This is 0.2% higher than average price of previous purchases of DGX. |
| MCK - McKesson Corporation | BUY | 204 @ USD 820.25 | USD 167,331 | The ETF bought 204 new shares of MCK (McKesson Corporation). The shares were bought for an average price of 820.25 compared to the previous average buy price of 711.566. This is 15.3% higher than average price of previous purchases of MCK. |
| ZTS - Zoetis Inc | BUY | 729 @ USD 122.24 | USD 89,113 | The ETF bought 729 new shares of ZTS (Zoetis Inc). The shares were bought for an average price of 122.24 compared to the previous average buy price of 150.818. This is -18.9% lower than average price of previous purchases of ZTS. |
| CAH - Cardinal Health Inc | BUY | 390 @ USD 202.95 | USD 79,151 | The ETF bought 390 new shares of CAH (Cardinal Health Inc). The shares were bought for an average price of 202.95 compared to the previous average buy price of 154.491. This is 31.4% higher than average price of previous purchases of CAH. |
| A - Agilent Technologies Inc | BUY | 468 @ USD 137.24 | USD 64,228 | The ETF bought 468 new shares of A (Agilent Technologies Inc). The shares were bought for an average price of 137.24 compared to the previous average buy price of 131.363. This is 4.5% higher than average price of previous purchases of A. |
| GEHC - GE HealthCare Technologies Inc. | BUY | 747 @ USD 82.89 | USD 61,919 | The ETF bought 747 new shares of GEHC (GE HealthCare Technologies Inc.). The shares were bought for an average price of 82.89 compared to the previous average buy price of 79.4406. This is 4.3% higher than average price of previous purchases of GEHC. |
| RMD - ResMed Inc | BUY | 243 @ USD 244.94 | USD 59,520 | The ETF bought 243 new shares of RMD (ResMed Inc). The shares were bought for an average price of 244.94 compared to the previous average buy price of 251.659. This is -2.7% lower than average price of previous purchases of RMD. |
| HUM - Hummingbird Resources PLC | BUY | 198 @ USD 259.4 | USD 51,361 | The ETF bought 198 new shares of HUM (Hummingbird Resources PLC). The shares were bought for an average price of 259.4 compared to the previous average buy price of 265.559. This is -2.3% lower than average price of previous purchases of HUM. |
| HUM - Humana Inc | BUY | 198 @ USD 259.4 | USD 51,361 | The ETF bought 198 new shares of HUM (Humana Inc). The shares were bought for an average price of 259.4 compared to the previous average buy price of 265.559. This is -2.3% lower than average price of previous purchases of HUM. |
| MTD - Mettler-Toledo International Inc | BUY | 33 @ USD 1402.51 | USD 46,283 | The ETF bought 33 new shares of MTD (Mettler-Toledo International Inc). The shares were bought for an average price of 1402.51 compared to the previous average buy price of 1302.4. This is 7.7% higher than average price of previous purchases of MTD. |
| MTD - AMUNDI EUR GOV 710 | BUY | 33 @ USD 1402.51 | USD 46,283 | The ETF bought 33 new shares of MTD (AMUNDI EUR GOV 710). The shares were bought for an average price of 1402.51 compared to the previous average buy price of 1302.4. This is 7.7% higher than average price of previous purchases of MTD. |
| DXCM - DexCom Inc | BUY | 645 @ USD 66.06 | USD 42,609 | The ETF bought 645 new shares of DXCM (DexCom Inc). The shares were bought for an average price of 66.06 compared to the previous average buy price of 73.9049. This is -10.6% lower than average price of previous purchases of DXCM. |
| BIIB - Biogen Inc | BUY | 237 @ USD 174.8 | USD 41,428 | The ETF bought 237 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 174.8 compared to the previous average buy price of 148.108. This is 18.0% higher than average price of previous purchases of BIIB. |
| WAT - Waters Corporation | BUY | 99 @ USD 378.03 | USD 37,425 | The ETF bought 99 new shares of WAT (Waters Corporation). The shares were bought for an average price of 378.03 compared to the previous average buy price of 353.64. This is 6.9% higher than average price of previous purchases of WAT. |
| WAT - MULETFWATIMETFP | BUY | 99 @ USD 378.03 | USD 37,425 | The ETF bought 99 new shares of WAT (MULETFWATIMETFP). The shares were bought for an average price of 378.03 compared to the previous average buy price of 353.64. This is 6.9% higher than average price of previous purchases of WAT. |
| LH - Laboratory Corporation of America Holdings | BUY | 138 @ USD 252.03 | USD 34,780 | The ETF bought 138 new shares of LH (Laboratory Corporation of America Holdings). The shares were bought for an average price of 252.03 compared to the previous average buy price of 257.396. This is -2.1% lower than average price of previous purchases of LH. |
| PODD - Insulet Corporation | BUY | 117 @ USD 289.62 | USD 33,886 | The ETF bought 117 new shares of PODD (Insulet Corporation). The shares were bought for an average price of 289.62 compared to the previous average buy price of 295.758. This is -2.1% lower than average price of previous purchases of PODD. |
| CNC - Concurrent Technologies Plc | BUY | 762 @ USD 39.02 | USD 29,733 | The ETF bought 762 new shares of CNC (Concurrent Technologies Plc). The shares were bought for an average price of 39.02 compared to the previous average buy price of 46.3603. This is -15.8% lower than average price of previous purchases of CNC. |
| ZBH - Zimmer Biomet Holdings Inc | BUY | 324 @ USD 89.13 | USD 28,878 | The ETF bought 324 new shares of ZBH (Zimmer Biomet Holdings Inc). The shares were bought for an average price of 89.13 compared to the previous average buy price of 101.141. This is -11.9% lower than average price of previous purchases of ZBH. |
| INCY - Incyte Corporation | BUY | 273 @ USD 102.69 | USD 28,034 | The ETF bought 273 new shares of INCY (Incyte Corporation). The shares were bought for an average price of 102.69 compared to the previous average buy price of 81.0742. This is 26.7% higher than average price of previous purchases of INCY. |
| COO - The Cooper Companies, Inc. Common Stock | BUY | 330 @ USD 82.75 | USD 27,308 | The ETF bought 330 new shares of COO (The Cooper Companies, Inc. Common Stock). The shares were bought for an average price of 82.75 compared to the previous average buy price of 80.7605. This is 2.5% higher than average price of previous purchases of COO. |
| HOLX - Hologic Inc | BUY | 363 @ USD 74.95 | USD 27,207 | The ETF bought 363 new shares of HOLX (Hologic Inc). The shares were bought for an average price of 74.95 compared to the previous average buy price of 68.843. This is 8.9% higher than average price of previous purchases of HOLX. |
| VTRS - Viatris Inc | BUY | 1,875 @ USD 11.93 | USD 22,369 | The ETF bought 1875 new shares of VTRS (Viatris Inc). The shares were bought for an average price of 11.93 compared to the previous average buy price of 10.4179. This is 14.5% higher than average price of previous purchases of VTRS. |
| SOLV - Solventum Corp. | BUY | 243 @ USD 81.59 | USD 19,826 | The ETF bought 243 new shares of SOLV (Solventum Corp.). The shares were bought for an average price of 81.59 compared to the previous average buy price of 74.1678. This is 10.0% higher than average price of previous purchases of SOLV. |
| MRNA - Moderna Inc | BUY | 558 @ USD 33.8 | USD 18,860 | The ETF bought 558 new shares of MRNA (Moderna Inc). The shares were bought for an average price of 33.8 compared to the previous average buy price of 30.1503. This is 12.1% higher than average price of previous purchases of MRNA. |
| ALGN - Align Technology Inc | BUY | 111 @ USD 157.69 | USD 17,504 | The ETF bought 111 new shares of ALGN (Align Technology Inc). The shares were bought for an average price of 157.69 compared to the previous average buy price of 166.795. This is -5.5% lower than average price of previous purchases of ALGN. |
| CRL - Creightons Plc | BUY | 81 @ USD 197.06 | USD 15,962 | The ETF bought 81 new shares of CRL (Creightons Plc). The shares were bought for an average price of 197.06 compared to the previous average buy price of 169.292. This is 16.4% higher than average price of previous purchases of CRL. |
| BAX - Baxter International Inc | BUY | 837 @ USD 18.96 | USD 15,870 | The ETF bought 837 new shares of BAX (Baxter International Inc). The shares were bought for an average price of 18.96 compared to the previous average buy price of 27.0166. This is -29.8% lower than average price of previous purchases of BAX. |
| TECH - Bio-Techne Corp | BUY | 255 @ USD 58.27 | USD 14,859 | The ETF bought 255 new shares of TECH (Bio-Techne Corp). The shares were bought for an average price of 58.27 compared to the previous average buy price of 60.5236. This is -3.7% lower than average price of previous purchases of TECH. |
| HSIC - Henry Schein Inc | BUY | 171 @ USD 77.35 | USD 13,227 | The ETF bought 171 new shares of HSIC (Henry Schein Inc). The shares were bought for an average price of 77.35 compared to the previous average buy price of 71.3299. This is 8.4% higher than average price of previous purchases of HSIC. |
| DVA - DaVita HealthCare Partners Inc | BUY | 60 @ USD 115.2 | USD 6,912 | The ETF bought 60 new shares of DVA (DaVita HealthCare Partners Inc). The shares were bought for an average price of 115.2 compared to the previous average buy price of 139.909. This is -17.7% lower than average price of previous purchases of DVA. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -134 @ USD 767.96 | USD -102,907 | The ETF sold 134 shares of REGN on 2025-12-19. The shares were previously bought for an average price of USD 662.79. The Regeneron Pharmaceuticals Inc shares were sold for 15.9% higher than average price of previous purchases. This sale made a profit of USD 14,093 The average price that the ETF previously sold REGN share for is USD 691.123 so the ETF has sold 134 shares on 2025-12-19 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -401 @ USD 340.69 | USD -136,617 | The ETF sold 401 shares of ELV on 2025-12-19. The shares were previously bought for an average price of USD 365.457. The Elevance Health Inc shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,932 The average price that the ETF previously sold ELV share for is USD 384.504 which is higher than the selling price of USD 340.69 on 2025-12-19. |
| ELV - Elevance Health Inc | SELL | -401 @ USD 340.69 | USD -136,617 | The ETF sold 401 shares of ELV on 2025-12-19. The shares were previously bought for an average price of USD 365.457. The Elevance Health Inc shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,932 The average price that the ETF previously sold ELV share for is USD 384.504 which is higher than the selling price of USD 340.69 on 2025-12-19. |
| EW - Edwards Lifesciences Corp | SELL | -1,709 @ USD 85.66 | USD -146,393 | The ETF sold 1709 shares of EW on 2025-12-19. The shares were previously bought for an average price of USD 76.0054. The Edwards Lifesciences Corp shares were sold for 12.7% higher than average price of previous purchases. This sale made a profit of USD 16,500 The average price that the ETF previously sold EW share for is USD 73.1136 so the ETF has sold 1709 shares on 2025-12-19 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -370 @ USD 456.2 | USD -168,794 | The ETF sold 370 shares of VRTX on 2025-12-19. The shares were previously bought for an average price of USD 442.691. The Vertex Pharmaceuticals Inc shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 4,998 The average price that the ETF previously sold VRTX share for is USD 457.42 which is higher than the selling price of USD 456.2 on 2025-12-19. |
| RVTY - Revvity Inc. | SELL | -2,155 @ USD 96.24 | USD -207,397 | The ETF sold 2155 shares of RVTY on 2025-12-19. The shares were previously bought for an average price of USD 102.676. The Revvity Inc. shares were sold for -6.3% lower than average price of previous purchases. This resulted in an overall loss of USD 13,870 The average price that the ETF previously sold RVTY share for is USD 107.414 which is higher than the selling price of USD 96.24 on 2025-12-19. |
| UHS - Universal Health Services Inc | SELL | -916 @ USD 227.46 | USD -208,353 | The ETF sold 916 shares of UHS on 2025-12-19. The shares were previously bought for an average price of USD 197.748. The Universal Health Services Inc shares were sold for 15.0% higher than average price of previous purchases. This sale made a profit of USD 27,216 The average price that the ETF previously sold UHS share for is USD 194.819 so the ETF has sold 916 shares on 2025-12-19 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -1,383 @ USD 163.69 | USD -226,383 | The ETF sold 1383 shares of MOH on 2025-12-19. The shares were previously bought for an average price of USD 230.472. The MOH shares were sold for -29.0% lower than average price of previous purchases. This resulted in an overall loss of USD 92,360 The average price that the ETF previously sold MOH share for is USD 282.243 which is higher than the selling price of USD 163.69 on 2025-12-19. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -1,383 @ USD 163.69 | USD -226,383 | The ETF sold 1383 shares of MOH on 2025-12-19. The shares were previously bought for an average price of USD 230.472. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -29.0% lower than average price of previous purchases. This resulted in an overall loss of USD 92,360 The average price that the ETF previously sold MOH share for is USD 282.243 which is higher than the selling price of USD 163.69 on 2025-12-19. |
| DHR - Danaher Corporation | SELL | -1,017 @ USD 224.84 | USD -228,662 | The ETF sold 1017 shares of DHR on 2025-12-19. The shares were previously bought for an average price of USD 214.675. The Danaher Corporation shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 10,338 The average price that the ETF previously sold DHR share for is USD 223.384 so the ETF has sold 1017 shares on 2025-12-19 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,017 @ USD 224.84 | USD -228,662 | The ETF sold 1017 shares of DHR on 2025-12-19. The shares were previously bought for an average price of USD 214.675. The Danaher Corporation shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 10,338 The average price that the ETF previously sold DHR share for is USD 223.384 so the ETF has sold 1017 shares on 2025-12-19 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -484 @ USD 572.47 | USD -277,075 | The ETF sold 484 shares of ISRG on 2025-12-19. The shares were previously bought for an average price of USD 521.681. The Intuitive Surgical Inc shares were sold for 9.7% higher than average price of previous purchases. This sale made a profit of USD 24,582 The average price that the ETF previously sold ISRG share for is USD 531.618 so the ETF has sold 484 shares on 2025-12-19 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -1,353 @ USD 472.98 | USD -639,942 | The ETF sold 1353 shares of HCA on 2025-12-19. The shares were previously bought for an average price of USD 393.849. The HCA Holdings Inc shares were sold for 20.1% higher than average price of previous purchases. This sale made a profit of USD 107,064 The average price that the ETF previously sold HCA share for is USD 363.159 so the ETF has sold 1353 shares on 2025-12-19 at a higher price than the previous selling average. |